Dr Angelo Alonzo is a research officer co-ordinating clinical trials of novel treatments for depression lead by chief investigator, Prof Colleen Loo.
Dr Angelo Alonzo completed his studies in psychology at the University of New South Wales with a BSc (Hons) and PhD in cognitive psychology. He has co-ordinated multiple clinical trials of transcranial Direct Current Stimulation (tDCS) based at the Black Dog Institute including an international, multicentre trial with five other study sites in the USA. He is currently co-ordinating an NHMRC funded, multicentre trial of ketamine for the treatment of depression comprised of 6 study sites in Australia and 1 in New Zealand. Complementing the clinical trial research, he is also involved in the activities and services of the Sydney Neurostimulation Centre based at the Black Dog Institute including the Transcranial Magnetic Stimulation (TMS) Clinic, TMS and tDCS courses and workshops, supervision of research projects by medical students from the University of New South Wales, and publication of research papers.